A Prospective, Controlled, Randomized, Multi-Center, Pivotal Study Evaluating the Safety and Efficacy of AdhexilTM in Prevention And/Or Reduction of Adhesions in Gynecology Surgery

Inclusion Criteria:

- Female patients aged 18-45 years at screening.

- Patients undergoing elective laparoscopic surgery involving at least one adnexa.

Exclusion Criteria:

- Pregnant (including ectopic pregnancy) or breastfeeding patient.

- Patients with a documented diagnosis of cancer.

- Patients with a lymphatic, hematologic or coagulation disorder.

- Patients with a known or suspected hypersensitivity to blood, blood products or any
constituent of Adhexil™.

- Patients who are immunocompromised, possess autoimmune disorders, or who are
routinely taking anticoagulants.

- Patients who have participated in another clinical study within 30 days of enrolment.

- Investigator's opinion that the patient is medically unfit or would be at major risk
if enrolled into the study.